8-K
Current Report
Keros Therapeutics, Inc. Filed Acc 0001664710-21-000052
Material agreement · Results of operations
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
From the SEC's structured data for this filing
Loading keros-form8xkq22021earning.htm…